CAS: 92262-58-3 - Valrocemide
Formula:C10H20N2O2
InChI:InChI=1S/C10H20N2O2/c1-3-5-8(6-4-2)10(14)12-7-9(11)13/h8H,3-7H2,1-2H3,(H2,11,13)(H,12,14)
InChI key:InChIKey=RALGCAOVRLYSMA-UHFFFAOYSA-N
SMILES:O=C(N)CNC(=O)C(CCC)CCC
- Sinonimi:
- (1Beta,8Xi,11Beta,12Alpha,15Beta)-1,11,12-Trihydroxy-15-Methoxy-11,20-Epoxypicrasa-3,13(21)-Diene-2,16-Dione
- N-(2-Amino-2-oxoethyl)-2-propylpentanamide
- N-Valproylglycinamide
- Pentanamide, N-(2-amino-2-oxoethyl)-2-propyl-
- Tv 1901
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | VALROCEMIDE REF: IN-DA00GRB9CAS: 92262-58-3 | 98% | 53,00 €~142,00 € | Mer 27 Nov 24 |
 | Valrocemide REF: TM-T3562CAS: 92262-58-3 | 99.9% | 44,00 €~105,00 € | Mer 04 Dic 24 |
 | Valrocemide REF: 3D-SDA26258CAS: 92262-58-3 | Min. 95% | Prezzo su richiesta | Mer 08 Gen 25 |
Ref: IN-DA00GRB9
| 5mg | 53,00 € | ||
| 10mg | 57,00 € | ||
| 25mg | 82,00 € | ||
| 100mg | 142,00 € |
Consegna stimata in Stati Uniti, il Mercoledì 27 Novembre 2024
Valrocemide
CAS:92262-58-3
Valrocemide (TV1901), a broad-spectrum AED, is under development by Teva and Acorda for epilepsy treatment.
Formula:
C10H20N2O2
Purezza:
99.9%
Colore e forma:
Solid
Peso molecolare:
200.28
Ref: TM-T3562
| 5mg | 46,00 € | ||
| 10mg | 60,00 € | ||
| 25mg | 44,00 € | ||
| 50mg | 78,00 € | ||
| 100mg | 105,00 € | ||
| 1mL*10mM (DMSO) | 51,00 € |
Consegna stimata in Stati Uniti, il Mercoledì 04 Dicembre 2024
Valrocemide
CAS:92262-58-3
Valrocemide is an amide laxative that is used to treat bowel disease. It is a …
Formula:
C10H20N2O2
Purezza:
Min. 95%
Peso molecolare:
200.28 g/mol
Ref: 3D-SDA26258
| 50mg | 219,00 € | ||
| 500mg | 869,00 € |
Consegna stimata in Stati Uniti, il Mercoledì 08 Gennaio 2025
